% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

  • saxpop7 saxpop7 Dec 22, 2010 8:18 AM Flag


    I would think that sales would be very strong with the new approval for migraine headaches. Does anyone have a clue?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Excellent point.
      Your logical assumption, plus AGN's history of strong 4th quarter performance -- along with positive "macro-economic" data showing better than average recovery -- I would anticipate that Allergan should report a good quarter driven by strong sales in it's Botox franchise.
      The "approval for migraine" will be huge. however; it will take about 4 to 6 quarters to reach it's full effect -- sort-a-like -- a rising tide effect.
      ***But also throw into the mix: Lap-Band expansion; and approval of other AGN's products in several global markets and you could make a case for geometric sales growth in this company's near future.
      What a bonanza!!!!!

225.72-7.79(-3.34%)Jun 24 4:03 PMEDT